While in theory, subsequent anti-PD-L1/PD-1 blockade could successfully target these cells, it is generally accepted that the success of cancer immunotherapy hinges upon the effective orchestration of the cancer-immunity cycle (CI cycle), a series of interconnected steps crucial for generating anti-tumor immune responses. Here, CD274 is linked to neoplasm.